- ホーム
- アプリ分析
- Hematology Masterclass
- Hematology Masterclass Vs. Chronic Lymphocytic Leukemia
Hematology Masterclass vs Chronic Lymphocytic Leukemia使用状況と統計
Name-tag, program, speakers and all what you need to attend 3rd Hematology Masterclass.
[:mav: 1.0.3]
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Chronic Lymphocytic Leukemia @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Chronic Lymphocytic Leukemia @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Chronic Lymphocytic Leukemia content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
Hematology Masterclass対Chronic Lymphocytic Leukemiaランキング比較
と過去28日間の Hematology Masterclass ランキング傾向を比較 Chronic Lymphocytic Leukemia
ランキング
ご利用可能なデータがありません
Hematology Masterclass 対 Chronic Lymphocytic Leukemia 国の比較によるランキング
と過去28日間の Hematology Masterclass ランキング傾向を比較 Chronic Lymphocytic Leukemia
表示できるデータはありません
無料トライアルで任意のサイトと比較する
Hematology Masterclass VS.
Chronic Lymphocytic Leukemia
12月 14, 2024